(Q71678974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Probing the V1a vasopressin receptor binding site with pyroglutamate-substituted linear antagonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

J Howl

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

N J Yarwood

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

D Stock

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

73-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

Molecular pharmacology of V1a vasopressin receptors.

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

No requirement of cyclic conformation of antagonists in binding to vasopressin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Conformational and structural considerations in oxytocin-receptor binding and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response t

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activity

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Pharmacological characterization of linear analogues of vasopressin generated by the systematic substitution of positions 1 and 6 by L-amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

A selective biotinylated probe for V1a vasopressin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Lack of V1 vasopressin receptors in rabbit hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Hypothalamic regulatory hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Bombesin:potent effects on thermoregulation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Design and synthesis of heterofunctional V1a-selective vasopressin receptor ligands with lysine at position 9

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990058-X

7 January 2021

10.1016/S0143-4179(96)90058-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8868303%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference